Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126693002 | 12669300 | 2 | F | 20160829 | 20160819 | 20160902 | EXP | US-PFIZER INC-2016385766 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126693002 | 12669300 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Vaginal | 0.5G, TWICE WEEKLY AT BEDTIME, STRENGHT 0.625MG | U | 20216 | .5 | G | VAGINAL CREAM | BIW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126693002 | 12669300 | 1 | Preoperative hormone treatment |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126693002 | 12669300 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126693002 | 12669300 | Product use issue | |
126693002 | 12669300 | Vaginal prolapse |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |